If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
Issue 1 May 2011
Drug Discovery & Development
Collaborative Action
Why open innovation is the way forward in the
development of ever more complex drugs
Pharma
Technology Focus
IN ASSOCIATION WITH
In this issue:
Cannabinoids rise above the stigma
The future is digital for clinical trials
Intelligent robots revolutionise lab work
Contents
Issue #1 May 2011
Open the Treasure Chest
Why open innovation is key to the development
of ever more complex drugs
BBMRI: The Industry Perspective
How big pharma is getting involved in a project
that could revolutionise medical research
Hope on the Horizon?
Treatment for HIV / Aids is more sophisticated
t developments
id Medicine
nnabis plant could
cal breakthroughs
nical IT
that can help make
re cost-effective
Scientist
g t
Issue 1 May 2011 Drug Discovery & Developmen
Contents Issue #1 May 2011 Open the
ICON’s Integrated Technology Solution A centralis
Industry News Navigation: Select a news catego
Integrated Safety in the Lab guaranteed by IKA®
OPEN THE TREASURE CHEST CONFRO
The simple diseases have been solved,” says Dr Pa
We have a challenging and inspiring mission: To i
BBMRI: The Industry Perspective The Bi
R&D
HOPE on the Horizon? Treatment for HIV / Aids is
aspen bad oldesloe gmbh industriestrasse 32-36 23
The Rise of A group of compounds found in the c
Cannabinoids, the class of chemical compoun
“That again opens the therapeutic window,” he say
This means that cannabinoids share a very good or
Online- Moisture Measurement in Granulation and D
1 10 01 TRIAL A
10 Along with the likes of expiring patents and t
Advertorial A Technology Solution for Improvi
EVOLUTION of the Robot Scientist In the increasin
Put simplistically, high throughput screening (HT
Honeywell Aclar® Film The Aclar® Advant
Pharma Technology Focus Editorial Duncan Wes
COMBINING THE 11TH ANNUAL ECLINICAL TRIALS AND 4T